二次注射胶原酶治疗腰椎间盘突出症的临床研究

目的 讨论二次注射胶原酶治疗腰椎间盘突出症的可行性及适应证.方法 对82例行二次注射胶原酶治疗的腰椎间盘突出症患者进行随访并对其临床疗效进行总结分析.结果 82例患者随访3～12个月,疗效优51例,良13例,可8例,差10例,总优良率为78%,有效率为88%,本组患者无一例出现并发症.结论 只要严格掌握二次胶原酶注射治疗腰椎间盘突出症的适应证,做好术前、术中、术后的过敏反应预防措施,二次注射胶原酶治疗腰椎间盘突出症是安全有效的.

The clinical study of twice chemonucleolysis with collagenase for the treatment of lumbar disc herniation

Objective To study the feasibility and indication of twice chemonucleolysis with collagenase for the treatment of lumbar disc herniation.Methods Eighty two patients of lumber disc herniation were treated with twice collagenase chemonucleolysis.All patients were followed up for 3 to 12 months and then the clinical results were assessed according to the Macnab criteria retrospectively.Results Eighty two cases were followed up from 3 to 12 months postoperatively.Fifty one cases were excellent,13 cases good,8 as fair and 10 were poor.The rate of excellent plus good reached 78%,the effective rate was 88%.Conclusion Twice chemonucleolysis with strict indications together with prevention of allergic reaction before,during and after the operation;is safe and effective for treating lumbar disc herniation.(J Intervent Radiol,2007,16:258-259)